250 related articles for article (PubMed ID: 32301482)
1. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
[TBL] [Abstract][Full Text] [Related]
2. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
[TBL] [Abstract][Full Text] [Related]
4. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
6. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
Sucquart IE; Nagarkar R; Edwards MC; Rodriguez Paris V; Aflatounian A; Bertoldo MJ; Campbell RE; Gilchrist RB; Begg DP; Handelsman DJ; Padmanabhan V; Anderson RA; Walters KA
Endocrinology; 2021 May; 162(5):. PubMed ID: 33522579
[TBL] [Abstract][Full Text] [Related]
7. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin protects against development of metabolic disturbances in a PCOS mouse model.
Benrick A; Chanclón B; Micallef P; Wu Y; Hadi L; Shelton JM; Stener-Victorin E; Wernstedt Asterholm I
Proc Natl Acad Sci U S A; 2017 Aug; 114(34):E7187-E7196. PubMed ID: 28790184
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model.
Rodriguez Paris V; Edwards MC; Aflatounian A; Bertoldo MJ; Ledger WL; Handelsman DJ; Gilchrist RB; Walters KA
J Endocr Soc; 2021 Jun; 5(6):bvab060. PubMed ID: 34056500
[TBL] [Abstract][Full Text] [Related]
10. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
11. Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS).
Brown RE; Wilkinson DA; Imran SA; Caraty A; Wilkinson M
Brain Res; 2012 Jul; 1467():1-9. PubMed ID: 22668987
[TBL] [Abstract][Full Text] [Related]
12. Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
Sun LF; Yang YL; Xiao TX; Li MX; Zhang JV
Reprod Fertil Dev; 2019 Sep; 31(10):1597-1606. PubMed ID: 31142430
[TBL] [Abstract][Full Text] [Related]
13. Increased uterine androgen receptor protein abundance results in implantation and mitochondrial defects in pregnant rats with hyperandrogenism and insulin resistance.
Zhang Y; Hu M; Yang F; Zhang Y; Ma S; Zhang D; Wang X; Sferruzzi-Perri AN; Wu X; Brännström M; Shao LR; Billig H
J Mol Med (Berl); 2021 Oct; 99(10):1427-1446. PubMed ID: 34180022
[TBL] [Abstract][Full Text] [Related]
14. Chronic androgen excess in female mice does not impact luteinizing hormone pulse frequency or putative GABAergic inputs to GnRH neurons.
Coyle CS; Prescott M; Handelsman DJ; Walters KA; Campbell RE
J Neuroendocrinol; 2022 Apr; 34(4):e13110. PubMed ID: 35267218
[TBL] [Abstract][Full Text] [Related]
15. Electroacupuncture improves metabolic and ovarian function in a rat model of polycystic ovary syndrome by decreasing white adipose tissue, increasing brown adipose tissue, and modulating the gut microbiota.
Zhang F; Ma T; Tong X; Liu Y; Cui P; Xu X; Shi J; Hu W; Lu W; Pei Z; Xu M; Li X; Xu C; Feng Y
Acupunct Med; 2022 Aug; 40(4):347-359. PubMed ID: 34892981
[TBL] [Abstract][Full Text] [Related]
16. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny and reversal of brain circuit abnormalities in a preclinical model of PCOS.
Silva MS; Prescott M; Campbell RE
JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618656
[TBL] [Abstract][Full Text] [Related]
18. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
[TBL] [Abstract][Full Text] [Related]
19. Neuronal Ptpn1 and Socs3 deletion improves metabolism but not anovulation in a mouse polycystic ovary syndrome model.
Kerbus RI; Inglis MA; Anderson GM
J Endocrinol; 2023 Sep; 259(1):. PubMed ID: 37466473
[TBL] [Abstract][Full Text] [Related]
20. Excess androgen during puberty disrupts circadian organization in female rats.
Sellix MT; Murphy ZC; Menaker M
Endocrinology; 2013 Apr; 154(4):1636-47. PubMed ID: 23417420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
